Generic “voor en na” pages show photos. This article shows something more useful for practitioners: how the treatment plan changes when the patient changes. Below are three complete case scenarios for RF microneedling — early skin laxity, jawline contouring, and acne scarring in darker skin — each with the reasoning behind the parameter choices, a day-by-day recovery timeline, and the assessment tools used to document results.
Belangrijk: These three cases are illustrative teaching scenarios, not real patient records. All values fall within published parameter ranges for the Morpheus8 / InMode platform and fractional RF microneedling literature, but the outcome numbers are placeholder-style examples showing how to document a case — not treatment promises, and not data for Mico Aes equipment. See the disclaimer at the end of this article.
1. What Makes a Case Study Worth Reading (and Worth Publishing)
Most before-and-after content fails because it skips the three things that make a case scientifically meaningful:
- Reproducible parameters — depth, energy (with units), mode, number of passes, pulse count, and tip type. “Energy 30” means nothing without knowing whether that’s a device level, joules, or kilowatts.
- Named assessment tools — validated scales such as the Fitzpatrick Elastosis Scale (FES), Alexiades-Armenakas Laxity Scale, Baker Face/Neck Classification, and GAIS, ideally scored by blinded assessors who did not perform the treatment.
- Controlled photography — same camera, lighting, distance, angle, and expression at every visit. Uncontrolled photos are marketing; controlled photos are evidence.
The three scenarios below are built around these principles. If you are a clinic building your own case library, Section 7 gives you the checklist our team recommends.
For the full clinical evidence picture, see our guide to Morpheus8 before-and-after results by skin concern.
2. The Literature Behind the Protocols
The parameter ranges used in these scenarios come from published practice protocols and studies on the Morpheus8 / InMode platform and fractional RF microneedling generally:
- A practice protocol for the 24-needle facial tip (Hendricks et al.) [1]: bony/fine areas (forehead, periorbital, cheeks, nose, perioral) treated with a depth-descending pattern (2 mm then 1 mm) at lower energy levels around 15–25; jawline, jowls, and submental zone treated at 5–7 passes, depths varying 1–4 mm, energy 20–45, targeting a minimum of 500 pulses per full face (up to 1,000 for severe laxity). The periorbital zone uses the 12-needle Prime tip: 2 mm × 2 passes (energy 20–25) + 1 mm × 2 passes (energy 15–20), at least 100 pulses per eye.
- Mode logic: at depths >2 mm, fixed mode is used with double-stacked pulses and ~50% handpiece overlap; at ≤2 mm, cycle mode is preferred to limit epidermal heat. No pulse stacking over thin skin or bony prominences.
- Energy by skin type (joule-based table, Hamadani et al.) [2]: Fitzpatrick I–II: 1.0–1.5 J (1–2 mm), 2.0–2.5 J (2–3 mm), 3.0–3.5 J (3–4 mm); III–IV: 0.8–1.2 / 1.5–2.0 / 2.5–3.0 J; V–VI: 0.5–0.8 / 1.0–1.5 / 2.0–2.5 J — darker skin types start lower and escalate gradually.
- Thermal target: reviews indicate the ideal thermal window is around 67°C held for 3–4 seconds; exceeding ~69.5°C causes collagen denaturation with worse clinical outcomes. Best treatment depth is considered ~1.3–2 mm for the reticular dermis — the basis for multi-depth (1–3 mm) treatment of laxity.
- Course structure: most sources recommend 3–4 sessions at 4–6 week intervals (some 6–8 weeks for aggressive protocols); deeper, higher-dose plans justify longer intervals.
- Outcome data (group level): a 247-patient retrospective study reported 93% improvement [3] in Baker Face/Neck laxity grades; a separate cohort showed ~85% of patients rating themselves [4] “much improved” of “very much improved” on GAIS; histology shows up to 25% collagen density and 33% elastin increases; texture studies report 20–30% elasticity gains En 25–35% pore reduction; acne scar reviews report 30–70% improvement after 3–4 sessions [5].
Again: these figures describe group outcomes on specific platforms and scales — they inform protocol design but do not guarantee individual results, and they do not transfer to other manufacturers’ equipment.
3. Case Study 1: Early Laxity & Enlarged Pores — Shallow Multi-Depth Strategy
Patient profile (illustrative): 35-year-old female, Fitzpatrick III. Chief complaints: visible pores, mild loss of firmness, early jawline blur. No fillers or neuromodulators in the past 12 months, no keloid history, no herpes history, no anticoagulants. Baseline scores: FES 2, Alexiades-Armenakas 2, Baker II.
The Planning Logic
The complaints are texture-dominant with mild laxity — not volume or fat. The goal is reticular dermal remodeling while protecting facial fat. Expert guidance explicitly recommends lower RF energy and shallower depths [6] in younger patients to avoid unwanted fat loss. The thermal literature supports this: the reticular dermis lives at ~1.3–2 mm, so a multi-depth 1–3 mm strategy covers the collagen target without reaching the fat layer at 4 mm.
Protocol
| Regio | Tip | Diepte | Energy (device level) | Modus | Passeert | Peulvruchten |
|---|---|---|---|---|---|---|
| Voorhoofd | 24-pin | 2 → 1 mm | 20 | Cyclus | 2 | 40 |
| Periorbital (each eye) | 12-pin Prime | 2 mm ×2 + 1 mm ×2 | 22 / 18 | Cyclus | 2+2 | ≥100/eye |
| Wangen | 24-pin | 2 → 1 mm | 25 → 20 | Cyclus | 3 | 120 |
| Kaaklijn | 24-pin | 3 → 2 mm | 30 → 25 | Fixed + Cycle | 3 | 150 |
| Total | - | - | - | - | - | ~620 |
Cursus: 3 sessions, 4-week intervals. Topical anesthesia 30 minutes pre-treatment.
Herstel & Nazorg
| Day | Expected course | Care |
|---|---|---|
| 0 | Redness grade 2, mild edema, pain VAS 4/10 | Air cooling (fan) 15 min; gentle cleanser only; no makeup 24 h |
| 1–2 | Pinkness fading; tightness | Prescribed gentle moisturizer; no retinoids/acids |
| 3–5 | Pinpoint crusting, flaking | No picking; SPF if outdoors |
| 5–7 | Settled; early glow | Resume routine as advised |
Cooling decision documented: fan cooling only, no ice packs, no NSAIDs — consistent with the rationale of preserving the prostaglandin-mediated inflammatory signal that drives collagen remodeling, and with platform guidance favoring air cooling with strict skin dryness before any device contact.
Documented Outcomes (illustrative values)
| Endpoint | Tool | Baseline | Day 90 | Day 180 |
|---|---|---|---|---|
| Laksheid | Alexiades-Armenakas | 2 | 2 | 1–2 |
| Wrinkles/elastosis | FES | 2 | 1–2 | 1–2 |
| Poriën | Texture analysis | grade 3 | −28% | −30% |
| Elasticity | Cutometer R2 | 0.63 | 0.70 (+11%) | 0.72 |
| Global improvement | GAIS (patient) | - | “Much improved” | “Much improved” |
| Blinded photo rating | 3 non-treating assessors | - | - | All 3 rate D180 > D0 |
Why this case is instructive: it demonstrates that “stronger” is not “beter.” A shallow, moderate-energy multi-depth plan delivered measurable texture, pore, and elasticity gains in a young patient — while deliberately avoiding the deep high-dose strategy that would have added recovery time and fat-loss risk without addressing the actual complaint.
4. Case Study 2: Jawline & Submental Fullness — Deep High-Dose Strategy
Patient profile (illustrative): 48-year-old female, Fitzpatrick IV. Chief complaints: “jawline disappeared,” submental fullness, neck laxity. Filler history: 1 ml chin hyaluronic acid 8 months ago (outside the 6-month exclusion window used by many protocols). No anticoagulants, no herpes history, no keloid history. Baseline: Baker Face/Neck III (jowls +, submental laxity ++, neck), Alexiades-Armenakas 3, FES 3. Objective baseline: high-frequency ultrasound of dermal/submental thickness + 3D photography of the jawline contour.
The Planning Logic
This complaint set is structure-dominant: jowls and submental fat require reaching the subcutaneous fat layer and fibrous septae. The published jawline/jowl/submental protocol exists precisely for this [1]: higher energy (20–45), depths up to 4 mm, 5–7 passes — accepting a longer recovery in exchange for contour change. Interval is extended to 6 weeks because deep high-dose treatments need longer repair windows.
Protocol
| Regio | Tip | Diepte | Energy (device level) | Modus | Passeert | Peulvruchten |
|---|---|---|---|---|---|---|
| Kaaklijn | 24-pin | 4 → 3 → 2 mm | 35 → 30 → 20 | Fixed (>2 mm) + Cycle (≤2 mm) | 5 | ~150 |
| Submental | 24-pin | 4 → 3 → 2 mm | 35 → 30 → 20 | Fixed + Cycle | 5 | ~100 |
| Nek | 24-pin | 3 → 2 mm | 30 → 25 | Fixed + Cycle | 3 (no stacking — thin skin) | 80 |
| Cheeks (supporting) | 24-pin | 3 → 2 → 1 mm | 30 / 25 / 20 | Fixed + Cycle | 3 | 120 |
| Periorbital | 12-pin Prime | per standard | lower range | Cyclus | standard | ≥100/eye |
| Total | - | - | - | - | - | ~780 |
Cursus: 3 sessions at 6-week intervals (longer interval justified by depth/intensity).
Herstel & Aftercare — the “Weeks, Not Days” Case
| Day | Expected course | Care |
|---|---|---|
| 0 | Redness grade 3, edema grade 3 (submental dominant), VAS 6/10 | Air cooling; written activity guidance |
| 1–3 | Edema grade 2 | Fan cooling; head elevation at night |
| 7 | Moderate edema + bruising still present | Expected for deep neck/submental work — not a complication |
| 14 | Edema largely resolved | - |
| 21 | Fully resolved | - |
Cooling decision documented: air cooling for the first 48 hours; from day 2, brief cloth-barrier cold compresses (10 min, 3×/day) for the submental swelling, with skin kept fully dry — the compromise position between “never ice” En “ice freely,” consistent with platform quick-reference guidance. No NSAIDs.
Documented Outcomes (illustrative values)
| Endpoint | Tool | Baseline | Day 90 | Day 180 |
|---|---|---|---|---|
| Neck aging grade | Baker Face/Neck | III | II | II |
| Laksheid | Alexiades-Armenakas | 3 | 2 | 2 |
| Dermal thickness | High-frequency ultrasound | baseline | +13% | +16% |
| Jawline contour | 3D photography | baseline angle | visible change | maintained |
| Global improvement | GAIS (patient) | - | “Much improved” | “Much improved” |
| Satisfaction | 0–10 | - | 8/10 | 8/10 |
Why this case is instructive: it shows the predictability conversation. The same device produced a days-level recovery in Case 1 and a weeks-level recovery here — entirely explained by depth, energy, passes, and treatment zone. The patient’s own feedback (“if I had known the swelling would last two weeks, I would have scheduled time off”) is the reason deep protocols warrant layered informed consent: written notice that submental/neck deep treatments can mean 2–4 weeks of visible swelling.
5. Case Study 3: Atrophic Acne Scars in Fitzpatrick V Skin — Low-Energy + Subcision
Patient profile (illustrative): 29-year-old male, Fitzpatrick V. Rolling and boxcar atrophic acne scars on cheeks and jawline, 10-year history. No hypertrophic scar or keloid history — recorded explicitly, because the literature is split: some sources consider insulated-needle RF microneedling suitable for scar-history patients, while most contraindication lists flag scar/keloid history as an exclusion [7]. Documented history details + risk assessment + explicit consent language is the defensible path. No active acne; no isotretinoin for >12 months.
The Planning Logic
Two decisions define this case. First, dark skin demands the energy ladder: the joule-based table puts Fitzpatrick V–VI at [2] 0.5–0.8 J (1–2 mm) En 1.0–1.5 J (2–3 mm) — roughly half the Fitzpatrick I–II values — with gradual escalation across sessions. The primary safety endpoint is post-inflammatoire hyperpigmentatie (PIH), not just efficacy. Second, rolling scars need release first: tumescent subcision to free the fibrous tethering bands, followed by RF microneedling in the same session — with both interventions documented separately so contribution can be discussed honestly in the limitations.
Protocol
| Sessie | Stap | Diepte | Energy (J, per Fitzpatrick V–VI table) | Modus | Passeert | Peulvruchten |
|---|---|---|---|---|---|---|
| 1 | Subcision of rolling scars (tumescent) | - | - | - | - | - |
| 1 | RF microneedling, cheeks/jaw | 2 → 1 mm | 0.5–0.8 J / lower | Cyclus | 3 | ~520 |
| 2 | RF microneedling (escalated) | 2 → 1 mm | up to 1.0–1.5 J @2–3 mm layer | Cyclus | 3 | ~550 |
| 3 | RF + shallow resurfacing tip | 0.5 mm added | session-2 levels | Cyclus | 3+1 | ~600 |
Cursus: 3 sessions at 6-week intervals. Attribution note: because subcision and RF microneedling occur in the same session, the case report must state that individual contributions cannot be fully separated.
Herstel & Nazorg
Same general timeline as Case 1 (day-level), with one extra monitoring item: daily pigmentation check through day 30 — in Fitzpatrick V skin, PIH can appear late and is the decisive safety endpoint.
Documented Outcomes (illustrative values)
| Endpoint | Tool | Baseline | Day 90 | Day 180 |
|---|---|---|---|---|
| Scar severity | Clinical grade | moderate | mild-moderate | mild-moderate |
| Scar texture | Texture analysis (R3) | baseline | −22% | −24% |
| Pigmentatie | PIH assessment | none | none | none |
| Global improvement | GAIS (patient) | - | “Much improved” | “Much improved” |
| Blinded photo rating | Assessors | - | - | 90% correctly identify D180 as post-treatment |
Why this case is instructive: it makes the energy–pigment trade-off explicit. Copying Fitzpatrick I–II settings onto V–VI skin would raise PIH risk substantially; halving the joules, preferring cycle mode (less epidermal heat per pulse), and escalating gradually across sessions is the documented middle path. The zero-PIH outcome at day 180 is the result worth publishing.
6. Side-by-Side: How the Protocol Logic Differs
| Dimension | Case 1: Texture/Early Laxity | Case 2: Jawline/Submental | Case 3: Acne Scars (Fitzpatrick V) |
|---|---|---|---|
| Primary target | Reticular dermis (collagen) | Dermis + subcutaneous septae | Scar remodeling + pigment safety |
| Depth strategy | Shallow multi-depth 1–3 mm | Deep 1–4 mm, multi-pass | Shallow 1–2 mm, joule-limited |
| Energy philosophy | Moderate (levels 15–30) | High (levels 20–45) | Low joules, escalate across sessions |
| Passeert | 2–3 | 5–7 (jaw/submental) | 3 |
| Interval | 4 weken | 6 weeks | 6 weeks |
| Recovery expectation | Days | Weeks (2–4 possible) | Days |
| Key safety endpoint | Comfort/fat preservation | Swelling counseling | PIH surveillance |
| Core lesson | Stronger ≠ better | Consent must match intensity | Skin type dictates the energy ladder |
One rule unifies all three: the complaint chooses the protocol — not the device maximum.
7. Documentation Checklist for Your Own Clinic Cases
Use this when building your before-and-after library (adapted from CARE case-report elements [8] and aesthetic-medicine consensus guidance [9]):
- Title discipline — region + complaint + device + Fitzpatrick type + follow-up length.
- Full parameter table — tip model, depth per zone, energy with units stated (device level/joules / kW are not interchangeable), mode, passes, stacking (yes/no), pulse count per zone and total.
- Mode rules stated — >2 mm fixed mode, ≤2 mm cycle mode, ~50% overlap, no stacking over thin skin or bone.
- Inclusion/exclusion audit — implants, pacemaker/ICD, pregnancy, isotretinoin history, anticoagulants, recent fillers/neuromodulators (product, layer, dose, interval), herpes history, scar/keloid history with individualized risk note.
- Named scales at baseline and follow-up — FES, Alexiades-Armenakas, Baker Face/Neck, WSRS, GAIS — plus the assessor setup (ideally three blinded non-treating reviewers).
- Objective measurements where available — Cutometer elasticity, texture analysis, high-frequency ultrasound dermal thickness, 3D contour/volume.
- Photography protocol — fixed camera/lighting/tripod/exposure, frontal + both lateral views, no retouching, timepoints at D0 / D30 / D90 / D180 (final-effect photos at D90–D180, because collagen maturation peaks late).
- Aftercare as a documented variable — cooling method and its rationale (the ice-pack debate has three legitimate positions; state yours and why), NSAID avoidance, skincare restrictions, SPF.
- Adverse event log — onset day, duration, grade, management, resolution, device relatedness.
- Consent & ethics — photo publication authorization, conflict of interest, off-label use disclosure if any.
- Results framing - “contour improvement” En “visible softening,” niet “volume increase X%,” unless 3D volumetric data exists.
- Platform attribution — state which device and manufacturer produced the photographs; keep generic marketing banners separate from documented cases.
For the treatment workflow itself, see our step-by-step Morpheus8 treatment guide; for aftercare products, see best moisturizer after Morpheus8.
8. Veelgestelde vragen
Can these three protocols be copied directly onto any RF microneedling machine?
No. Parameter values are platform- and tip-specific. Use them as decision logic (shallow vs. deep, energy ladder by skin type, pass count by complaint), then convert to your own device’s manual.
Why does Case 2 take weeks to recover when Case 1 takes days?
Depth, energy, pass count, and treatment zone. Reaching subcutaneous fat (4 mm, high energy, 5–7 passes in the submental zone) produces swelling that peaks later and lasts longer. This is expected physiology, not a complication — but it must be in the consent form.
Is ice allowed after RF microneedling?
The industry genuinely disagrees. Positions range from “never ice — protect the inflammatory healing signal” naar “cloth-wrapped cold compresses are fine.” The platform’s own quick-reference favors air cooling first [10], permits other cooling with clean technique and fully dry skin, and many protocols add no NSAIDs. Pick a position, document it, and stay consistent.
What is the single most common documentation failure?
Missing units on energy, followed closely by unblinded, uncontrolled photography. Both are cheap to fix and both are what separates a publishable case from a marketing banner.
Are Mico Aes machines the same as the InMode Morpheus8 used in these protocols?
No. Morpheus8 is an InMode platform. Mico Aes supplies separate professional RF microneedling equipment; evaluate every machine by its actual manufacturer, model, and documentation.
9. Conclusie
These three scenarios share one message: in RF microneedling, the planning is the treatment. The same device class, used shallow and moderate, remodels texture in a 35-year-old with days of downtime; used intense, it reshapes a jawline at the cost of a two-to-four-week recovery; used cautiously at low joules, it treats acne scars in Fitzpatrick V skin with pigmentation safety as the headline outcome. Clinics that document this logic — parameters with units, named scales, controlled photos, honest aftercare records — turn before-and-after content from advertising into an asset that survives scrutiny.
[[Explore professional RF microneedling equipment →](https://micoaes.com/product/microneedling-rf-morpheus8-machine-for-sale/)
Vrijwaring: The three case studies in this article are illustrative educational scenarios. Patient profiles are composite teaching examples; outcome values are placeholder-style documentation examples drawn from published parameter ranges, not real patient records or treatment guarantees. Literature figures cited describe group-level outcomes on specific platforms (including the InMode Morpheus8) and do not apply to other manufacturers’ devices. Treatment parameters must always follow the manual of the specific device being used, under qualified clinical supervision with appropriate consent.
Referenties
[1] Hendricks A, et al. Morpheus8 fractional radiofrequency microneedling treatment protocol for facial skin (24-needle tip; periorbital Prime tip protocol). Tijdschrift voor Cosmetische Dermatologie / published practice protocol. Parameter ranges: bony areas 2→1 mm at energy levels 15–25; jawline/jowls/submental 5–7 passes at 1–4 mm, energy 20–45; ≥500 pulses per full face; periorbital 12-pin Prime tip 2 mm×2 (20–25) + 1 mm×2 (15–20), ≥100 pulses per eye.
[2] Hamadani S, et al. Energy settings by Fitzpatrick skin type and needle depth for fractional RF microneedling (1–2 mm / 2–3 mm / 3–4 mm joule table; Fitzpatrick V–VI: 0.5–0.8 / 1.0–1.5 / 2.0–2.5 J). Treatment directed deep-to-superficial; fixed mode >2 mm, cycle mode ≤2 mm.
[3] Retrospective study of 247 patients treated with bipolar fractional RF devices including Morpheus8: 93% improved on Baker Face/Neck Classification; high satisfaction and willingness to retreat. Cited in platform clinical summaries and reviews of RF microneedling for facial/neck laxity.
[4] Clinical cohort data: approximately 85% of patients self-rated “much improved” of “very much improved” on the Global Aesthetic Improvement Scale (GAIS) after fractional RF microneedling treatment.
[5] Review literature on fractional RF microneedling for acne scars: 30–70% improvement after 3–4 sessions; split-face data showing scar-score reductions comparable to fractional CO₂ laser.
[6] Expert consensus guidance: lower RF energy and shallower depths recommended in younger patients / volume-sensitive faces to avoid unwanted fat loss from deep high-dose treatment.
[7] Standard contraindication and exclusion lists for RF microneedling: hypertrophic scar / keloid history, implanted electronic devices, pregnancy, active infection, recent isotretinoin (6–12 months), anticoagulant therapy, recent filler/neuromodulator injections. Individual risk documentation recommended where sources conflict.
[8] Gagnier JJ, et al. The CARE Guidelines: Consensus-based Clinical Case Reporting Guideline Development. Journal of Clinical Epidemiology, 2014. 13 core elements for case reports.
[9] Rahman I, Philip-Dormston W, et al. Developing consensus-based guidelines for case reporting in aesthetic medicine: enhancing transparency and standardization (CREAM guidelines). Aesthetic Surgery Journal, 2023.
[10] InMode Morpheus8 Operator Quick Reference: air cooling recommended for treated skin; alternative cooling permitted with clean technique and fully dry skin to prevent arcing; comfort measures including sterile cold packs noted.
[11] U.S. FDA. Potential Risks of Certain Uses of Radiofrequency (RF) Microneedling — FDA Safety Communication. https://www.fda.gov/medical-devices/safety-communications/potential-risks-certain-uses-radiofrequency-rf-microneedling-fda-safety-communication
[12] Blinded-assessment methodology in platform clinical studies: three blinded non-treating physician reviewers graded standardized before/after photographs using validated scales (Fitzpatrick Elastosis Scale, Alexiades-Armenakas Laxity Scale, Baker Face/Neck Classification).
Note on sources: [1]–[7] and [10]–[12] describe the InMode Morpheus8 platform or fractional RF microneedling literature generally. They are cited as protocol-design references only and do not constitute evidence for Mico Aes equipment. Where a full citation (volume/pages/DOI) is required for academic use, verify against the original publications before publishing.
Meer gerelateerde blogs:
- [Morpheus8 Before and After: Results, Recovery Timeline & Kosten 2026]
- Morpheus8: de toekomst van huidverjonging
- Morpheus8 versus traditionele microneedling RF: een uitgebreide vergelijking
- How to Do the Morpheus8 Treatment Step by Step
- Hoe lang duurt het voordat u Morpheus8-resultaten ziet?
- Best Moisturizer After Morpheus8
- Fibroblast Plasma vs. Morpheus8: Which Treatment Is Right for You?
